Mathur A, Lynch R G
J Immunol. 1986 Jan;136(2):521-5.
The results of previous studies in our laboratory have shown that mice bearing plasmacytomas and hybridomas that secrete IgA or IgE are accompanied by increased frequencies of Lyt-1-2+ T lymphocytes bearing Fc receptors (FcR) for IgA (T alpha) or IgE (T epsilon), respectively. The present study was undertaken to examine whether IgG- or IgM-secreting tumors influenced the frequency of T lymphocytes that express FcR for IgG or IgM. We studied mice bearing IgG- and IgM-secreting plasmacytomas and hybridomas. BALB/c mice injected subcutaneously with the IgG-secreting hybridoma HDP1 (gamma 1 kappa, anti-TNP) were sequentially examined for the frequencies and Lyt phenotypes of splenic lymphocytes bearing FcR for IgG (T gamma), IgM (T mu), and IgA (T alpha). A threefold increase in the frequency of T gamma lymphocytes that were Lyt-1-2+, L3T4- was seen. The frequencies of T mu and T alpha lymphocytes in these mice were not significantly altered. Similarly, mice injected subcutaneously with the IgM-secreting plasmacytoma MOPC 104E (mu lambda, anti-dextran) or the IgM-secreting hybridoma C1D1 (mu kappa, anti-ox RBC) were examined sequentially for the frequencies of T gamma, T mu, and T alpha lymphocytes. Mice with established IgM subcutaneous tumors showed a twofold increase in splenic, nylon wool-nonadherent T mu lymphocytes. This was associated with a relative increase in Lyt-2+ splenic T lymphocytes and a relative decrease in Lyt-1+ splenic T lymphocytes. No changes were observed in the frequencies of either T gamma or T alpha lymphocytes. These studies extend to IgG and IgM the observation that plasmacytomas and hybridomas secreting immunoglobulins of a specific isotype cause an expansion of T lymphocytes bearing FcR specific for the corresponding isotype. The expansion of FcR+ Lyt-1-2+ T lymphocytes likely represents an exaggerated, but otherwise normal, immunoregulatory response of the host. These cells may be an important element in the regulation of isotype expression.
我们实验室之前的研究结果表明,携带分泌IgA或IgE的浆细胞瘤和杂交瘤的小鼠,分别伴有携带IgA(Tα)或IgE(Tε)的Fc受体(FcR)的Lyt-1-2 + T淋巴细胞频率增加。本研究旨在检验分泌IgG或IgM的肿瘤是否会影响表达IgG或IgM的FcR的T淋巴细胞频率。我们研究了携带分泌IgG和IgM的浆细胞瘤和杂交瘤的小鼠。皮下注射分泌IgG的杂交瘤HDP1(γ1κ,抗TNP)的BALB/c小鼠,被依次检测携带IgG(Tγ)、IgM(Tμ)和IgA(Tα)的FcR的脾淋巴细胞的频率和Lyt表型。发现Lyt-1-2 +、L3T4-的Tγ淋巴细胞频率增加了三倍。这些小鼠中Tμ和Tα淋巴细胞的频率没有明显改变。同样,皮下注射分泌IgM的浆细胞瘤MOPC 104E(μπ,抗右旋糖酐)或分泌IgM的杂交瘤C1D1(μκ,抗氧红细胞)的小鼠,被依次检测Tγ、Tμ和Tα淋巴细胞的频率。患有已形成的IgM皮下肿瘤的小鼠,脾尼龙毛非黏附性Tμ淋巴细胞增加了两倍。这与Lyt-2 +脾T淋巴细胞的相对增加和Lyt- +脾T淋巴细胞的相对减少有关。Tγ或Tα淋巴细胞的频率没有观察到变化。这些研究将如下观察结果扩展到了IgG和IgM:分泌特定同种型免疫球蛋白的浆细胞瘤和杂交瘤会导致携带对应同种型特异性FcR的T淋巴细胞扩增。FcR + Lyt-1-2 + T淋巴细胞的扩增可能代表宿主一种过度但正常的免疫调节反应。这些细胞可能是同种型表达调节中的一个重要因素。